Sign in

CIK 0001855175

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
271467257
Phone
+1 858-333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,142
in 1 filing, $41K under 10b5-1 plans

Net −$41,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stengone Carmine N. −$41K CEO and President sold 13% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-26 Boyce Sarah Director Grant or award · Stock Option (right to buy) +19,000 19,000
2025-06-26 Boyce Sarah Director Grant or award · Stock Option (right to buy) +14,750 14,750
2024-06-24 Boyce Sarah Director Grant or award · Stock Option (right to buy) +29,500 29,500

Page 1 of 1 · 3 trades